Inhalation Sciences Sweden AB Stock NORDIC GROWTH MARKET
Stocks
ISAB
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.340 SEK | +6.90% |
|
-.--% | - |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| 05-29 | Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall | FW |
| Market Cap | 11.62M 1.21M 1.05M 972K 896K 1.69M 116M 1.73M 4.57M 56.87M 4.53M 4.43M 196M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 8.79M 912K 797K 735K 678K 1.28M 87.83M 1.31M 3.46M 43.02M 3.43M 3.35M 148M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 2019-09-15 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 2004-12-31 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 2025-06-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 2004-12-31 |
Jan Hellqvist
BRD | Director/Board Member | - | 2022-08-31 |
Ulf Ericsson
BRD | Director/Board Member | - | 2024-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.90% | -.--% | - | - | 1.21M | |
| -1.97% | +1.03% | +28.39% | -0.57% | 198B | |
| -0.58% | +2.40% | +7.25% | -16.42% | 144B | |
| -14.15% | -15.08% | -33.40% | -1.22% | 122B | |
| -1.32% | -1.65% | -57.52% | -15.88% | 65.44B | |
| -2.40% | -7.03% | +12.08% | -6.43% | 49.36B | |
| -0.11% | +1.53% | -23.83% | -31.33% | 44.74B | |
| -3.41% | -2.11% | +15.33% | +6.81% | 37.13B | |
| -2.44% | -1.98% | +28.33% | +31.74% | 36.23B | |
| -1.86% | -2.39% | -22.85% | -8.74% | 28.7B | |
| Average | -2.13% | -2.81% | -5.14% | -4.67% | 80.68B | |
| Weighted average by Cap. | -3.69% | -2.62% | -0.99% | -5.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.15M 1M 924K 852K 1.61M 110M 1.64M 4.35M 54.06M 4.3M 4.21M 186M | 3.04M 316K 276K 254K 235K 442K 30.38M 452K 1.2M 14.88M 1.18M 1.16M 51.23M |
| Net income | -5.15M -534K -467K -431K -397K -748K -51.42M -765K -2.02M -25.19M -2.01M -1.96M -86.7M | -10.16M -1.05M -921K -850K -784K -1.48M -102M -1.51M -4M -49.72M -3.96M -3.87M -171M |
| Net Debt | -4M -415K -363K -335K -309K -582K -39.99M -595K -1.57M -19.59M -1.56M -1.53M -67.43M | -2.83M -294K -257K -237K -218K -411K -28.29M -421K -1.11M -13.85M -1.1M -1.08M -47.69M |
Employees
-
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- ISAB Stock
Select your edition
All financial news and data tailored to specific country editions
